In vivo MR tracking of mesenchymal stem cells in rat liver after intrasplenic transplantation

Radiology

Volumn 245, Issue 1, 2007, Pages 206-215

  Ju, Shenghong ^a   Teng, Gao Jun ^a   Lu, Haihua ^a   Zhang, Yu ^a   Zhang, Aifeng ^a   Chen, Feng ^a,b   Ni, Yicheng ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC FERROCYANIDE; POLYLYSINE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL LABELING; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; IN VIVO STUDY; LIVER INJURY; LIVER SINUSOID; LIVER TRANSPLANTATION; MEASUREMENT; MESENCHYMAL STEM CELL TRANSPLANTATION; MORPHOMETRICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUNCTURE; RAT; SIGNAL NOISE RATIO; SPLEEN; STATISTICAL ANALYSIS;

ANIMALS; CELLS, CULTURED; FERRIC COMPOUNDS; FERROCYANIDES; LIVER; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; RATS; SPLEEN;

EID: 34548689160     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2443061290     Document Type: Article

References (47)

1. Allen KJ, Soriano HE. Liver cell transplantation: the road to clinical application. J Lab Clin Med 2001;138:298-312.
2. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168-1170.
3. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-1234.
4. Avital I, Inderbitzin D, Aoki T, et al. Isolation, characterization, and transplantation of bone marrow-derived hepatoeyte stem cells. Biochem Biophys Res Commun 2001;288:156-164.
5. Schwartz RK, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyle-like cells. J Clin Invest 2002;109:1291-1302.
6. Wang PP, Wang JH, Van ZP, et al. Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF inductions. Biochem Biophys Res Commun 2004;320:712-716.
7. Lee KD, Kuo TK, Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004;40:1275-1284.
8. Yamamoto N, Terai S, Ohata S, et al. A subpopulation of bone cells depleted by a novel antibody, anti-Liv8, is useful for cell therapy to repair damaged liver. Biochem Biophys Res Common 2004;313:1110-1118.
9. Sato Y, Araki H, Kato J, et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005;106:756-763.
10. Bulte JW, Douglas T, Witwer B, et al. Monitoring stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents. Acad Radiol 2002;9(suppl 2):S332-S335.
11. Soriano HH, Lewis D, Legner M, et al. The use of DH-marked hepatocytes to demonstrate orthotopic, intrahepatic engraftment following hepatocellular transplantation. Transplantation 1992;54:717-723.
12. Bulte JW, Zhang SC, van Gelderen P, et al. Magnetically labeled glial cells as cellular MR contrast agents. Acad Radiol 2002;9(suppl 1):S148-S150.
13. Modo M, Cash D, Mellodew K, et al. Tracking transplanted stein cell migration using bifunctional, contrast agent-enhanced magnetic resonance imaging. NeuroImage 2002;17:803-811.
14. Ju S, Teng G, Mao X, et al. In vitro labeling and MR imaging of mesenchymal stem cells from human umbilical cord blood. Magn Reson Imaging 2006;24(6):611-617.
15. Ponder KP, Gupta S, Leland F, et al. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A 1991;88:1217-1221.
16. Gupta S, Rajvanshi P, Lee CD. Integration of transplanted hepatocytes into host liver plates demonstrated with dipeptidyl peptidase IV-deficient rats. Proc Natl Acad Sci U S A 1995;92:5860-5864.
17. Rajvanshi P, Kerr A, Bhargava KK, Burk RD, Gupta S. Studies of liver repopulation using the dipeptidyl peptidase IV-deficient rat and other rodent recipients: cell size and structure relationships regulate, capacity for increased transplanted hepatocyte mass in the liver lobule. Hepatology 1996;23:482-496.
18. Ma M, Zhang Y, Yu W, Shen H, Zhang H, Gu N. Preparation and characterization of magnetite nanoparticles coated by amino silane. Coll Surf 2003;212:219-226.
19. Ma M, Wu Y, Zhou J, Sun Y, Zhang Y, Gu N. Size-dependence of specific power absorption of Fe3O4 particles in AC magnetic field. J Magn Mater 2003;268:33-39.
20. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74.
21. Aubin JE. Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell-cell interactions in osteoblast differentiation. J Cell Biochem 1999;72:396-410.
22. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000;164:247-256.
23. Dezawa M, Kanno H, Hoshino M, et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 2004;113:1701-1710.
24. Recknagel RO, Glende EA, Dolak JA, et al. Mechanism of CCl4 toxicity. Pharmacol Ther 1989;43:139-154.
25. Wolff SD, Balaban RS. Assessing contrast on MR images. Radiology 1997;202:25-29. [Published correction appears in Radiology 1997;202:880-881.)
26. Liu L, Tang M, Gu N, et al. Study on acute and chronic toxicity to rats of nanoparticles of Fe2O3 coated with glutamic acid [in Chinese]. J Environ Occup Med 2004;21:430-433.
27. Li Q, Tang M, Ban T, Ma M, Gu N. Study on cytotoxicity and oxidative effects of different sizes of Fe2O3 nanoparticles on CHL cells in vitro [in Chinese]. Chin J Public Health 2005;21:589-591.
28. Yin Q, Liu L, Gu N, et al. Determining the biodistribution of nano-Fe2O3-Glu in mice by 59Fe tracer and preparation [in Chinese]. J Med Postgrad 2005;18:312-317.
29. Kassem M, Kristiansen M, Abdallah BM, et al. Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 2004;95:209-214.
30. Henne-Bruns D, Kruger U, Sumpelmann D, Lierse W, Kremer B. Intraperitoneal hepatocyte transplantation: morphological results. Virchows Arch A Pathol Anat Histopathol 1991;419:45-50.
31. Gupta S, Yerneni PR, Vemuru RP, Lee CD, Yellin EL, Bhargava KK. Studies on the safety of intrasplenic hepatocyte transplantation: relevance to ex vivo gene therapy and liver repopulation in acute hepatic failure. Hum Gene Ther 1993;4:249-257.
32. Gupta S, Lee CD, Vemuru RP, Bhargava KK. 111Indium labeling of hepatocytes for analysis of short-term biodistribution of transplanted cells. Hepatology 1994;19:750-757.
33. Gupta S, Aragona E, Vemuru RP, Bhargava KK, Burk RD, Chowdhury JR. Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation. Hepatology 1991;14:144-149.
34. Unger EC. How can superparamagnetic iron oxides be used to monitor disease and treatment? Radiology 2003;229:615-616.
35. Yeh TC, Zhang W, Ildstad ST, Ho C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magn Reson Med 1995;33:200-208.
36. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 1999;10:186-191.
37. Daldrup-Link HE, Rudelius M, Oostendorp RA, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003;228:760-767.
38. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003;228:480-487.
39. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 2002;48:52-61.
40. Bos C, Delmas Y, Desmouliere A, et al. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 2004;233:781-789.
41. Arbab AS, Jordan EK, Wilson LB, Yocura GT, Lewis BK, Frank JA. In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther 2004;15:351-360.
42. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001;169:12-20.
43. Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003;107:2134-2139.
44. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003;107:2290-2293.
45. Hill JM, Dick JA, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003;108:1009-1014.
46. Bulte JW, Zhang S, van Gelderen P, et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 1999;96:15256-15261.
47. Hoehn M, Kustermann E, Blunk J, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 2002;99:16267-16272.